Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Mydecine Innovations Group Inc (MYCOF) Message Board

Rates of PTSD High Among Athletes While almost

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 160
(Total Views: 255)
Posted On: 03/22/2022 4:46:23 PM
Avatar
Posted By: NetworkNewsWire
Rates of PTSD High Among Athletes

While almost every individual will experience a traumatic event at least once in their lifetime, not everybody will develop post-traumatic stress disorder (“PTSD”). Research has found that unlike the general population, some groups do undergo experiences that make them more susceptible to PTSD. For instance, members of the military have some of the highest rates, at 38%, with 33% of ICU nurses and 18% of nurses also meeting the diagnostic criteria for post-traumatic stress disorder. Studies have now found that this disorder is also common in athletes, with estimates ranging from 13% to 25%.

PTSD is classified with stressor and trauma-related disorders under the Diagnostic and Statistical Manual of Mental Disorders by the American Psychiatric Association. The disorder usually occurs when an individual is exposed to an event that threatens sexual violence, bodily harm or death. Athletes sometimes experience bodily harm, which may cause PTSD to develop.

Post-traumatic stress disorder symptoms are usually classified in four categories, including marked arousal and reactivity, negative or worsening moods, avoidance of stimuli related to the event and symptoms associated with the event. These symptoms may persist for more than a month, which may result in significant distress and not be associated with prescribed medications or other substance use.

Intrusive symptoms include various types of distressing thoughts, such as recurring memories, traumatic dreams and flashbacks. To be diagnosed, a patient must be suffering from at least one of these symptoms.

Cheerleading has the a high number of injuries that result in death, temporary loss of function or permanent disability, including skull fractures, brain bleeds and spinal cord injuries, while football has the most injuries among players in both games as well as in practice.

Research conducted in 2018 also found that athletes who suffer concussions have a higher chance of developing post-traumatic stress disorder. The researchers explained that in comparison to a healthy control group, athletes who suffered concussions demonstrated symptoms of post-traumatic stress disorder.

An estimated 19% of the athletes also revealed that they tried avoiding situations that reminded them of their injuries, with about a quarter admitting to having trouble sleeping and others reporting that they relived their incident through flashbacks or had intrusive thoughts about it.

In their conclusion, the study’s authors stated that while their physical symptoms resolved on their own, athletes could develop this traumatic disorder even after recovering from the physical damage. They recommended that sports programs adopt screening for PTSD for concussed athletes. Other studies have also recommended that athletes receive proper mental health treatment after they have witnessed or experienced trauma, and there could soon be revolutionary mental health treatments if the psychedelic research and development being undertaken by companies such as Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: ONFA) is anything to go by.

NOTE TO INVESTORS: The latest news and updates relating to Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) are available in the company’s newsroom at https://ibn.fm/MYCOF

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer




(0)
(0)




Mydecine Innovations Group Inc (MYCOF) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us